Moreover, Il18, which encodes a proinflammatory cytokine that may enhance anti-tumor ability of natural killer cells against CRC, was among the most downregulated genes following regorafenib treatment, alone or in combination with autogramin-2 (Figure 3B) (Li et al., 2021). The gene discussed is IL18; the disease is colorectal carcinoma.